YOKOHAMA, Japan--(BUSINESS WIRE)--ReproCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the ReproCELL Group to expand the product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback